The pharmaceuticals sector is expected to post a revenue growth of around 13.5 per cent and a net profit growth of 30.3 per cent for the third quarter of 2023-24 (FY24), riding on the approval for niche drugs in the US market, fall in raw material prices and correction in shipping rates. In the healthcare segment, hospitals are expected to post revenue growth of 13 per cent during the coverage, while net profit growth would be around 37 per cent, ICICI Securities said in a note. However, the performance may not be comparable on a sequential basis due to the offset of the festive season in Q3FY24, the analysts noted.
On Thursday, May 12, 2022, Rahul Bhat, a government employee belonging to the Kashmiri Pandit community, was murdered by terrorists at his office in the Chadoora area of Budgam in Srinagar.
The pharmacy, identified by the federal anti-narcotics agency as JR Infinity Pvt Ltd, was located at Domalguda in Telangana's capital city.
Billionaire Gautam Adani's group has created a new company for its foray into healthcare services through the acquisition of large hospitals, diagnostic chains, and offline and digital pharmacies. Adani Enterprises Ltd - the group's business incubator firm - in a regulatory filing said a wholly-owned subsidiary, Adani Health Ventures Ltd (AHVL) was incorporated on May 17, 2022. AVHL will "carry on the business of healthcare-related activities including, inter alia, setting up, running, administrating medical and diagnostic facilities, health aids, health tech-based facilities, research centers and to do all other allied and incidental activities in this regard," it said.
While the opposition party asked the government to stop boasting about India being a pharmacy to the world and take strictest action, the ruling party accused it of deriding India in its "hate" for Prime Minister Narendra Modi.
Drug major Cipla on Tuesday said it has launched drone-powered deliveries of critical medicines - cardiac, respiratory and other essential chronic therapies - to hospitals and pharmacies across Himachal Pradesh in partnership with Skype Air Mobility, a Gurugram-based drone delivery company. Cipla is the first among large Indian pharmaceutical companies to adopt drone-based deliveries to facilitate expedited supply to stockists in remote areas, it claimed. The Mumbai-based firm said the use of drones will support the on-time delivery of its medicines to chemists and clinics in remote areas, and minimise risks of affecting cold chain products due to temperature excursions.
'Now that we are a pure-play India business, many investors are open to investing.'
Merry Christmas has a breathtaking climax that will have you sighing like you've never sighed in a Sriram Raghavan movie before, applauds Sukanya Verma.
However, Rajya Sabha being a continuing chamber is not subject to dissolution, and bills introduced and pending in this House remain on the live register, unless withdrawn by the government.
Abbott India outperformed the Indian pharmaceutical market (IPM) with a year-on-year (YoY) growth of 23 per cent in February. The domestic market grew at a robust 20 per cent on a low base, primarily led by volume growth and price hikes. Abbott continued to outperform the sector in the anti-diabetic space with a growth of 20 per cent and key brands such as Thyronorm (hypothyroidism), biliary agent Udiliv, insulin Ryzodeg posted robust growth.
In an exclusive interview with PTI video, the minister also said an extensive risk-based analysis is done continuously to ensure the production of quality medicines in the country, and the government and regulators are always alert to ensure that no one dies due to spurious medicines.
'We've got a huge track record and success in bringing several biosimilars to the market.'
At the outset, all eyes will be on the Lok Sabha Secretariat on Monday when it is expected to review the stay granted by the Supreme Court on the conviction of Rahul Gandhi in the 'Modi surname' case and decide on the revocation of his Parliament membership.
As COVID-19 cases in China continue to rise, Beijing will soon start distributing Pfizer's Covid-19 drug Paxlovid to the community health centres in forthcoming days, CNN reported citing state media on Monday.
The Indian Council of Medical Research is conducting three different studies to ascertain the facts regarding rising cases of cardiac arrest after the pandemic, Mandaviya said in response to a question in the Lok Sabha.
Terrorists belonging to banned groups United National Liberation Front (UNLF) and People's Liberation Army (PLA) were allegedly part of the mob from which gunshots were fired at an army officer that left him severely injured in Manipur, officials said Monday.
Quoting data collected from various sources, officials closely monitoring the situation here said that .303 rifles, Medium Machine Guns (MMG) and AK assault rifles, carbines, Insas Light Machine Guns (LMG), Insas rifles, M-16 and MP5 rifles were reported to be missing from the armouries of the police in May.
The online pharmacy market, which was worth about $512 million in 2018, is growing at a CAGR of 63 per cent and is expected to hit overall revenues of over $3.6 billion by 2022.
The Sikkim Government has confirmed that 14 people have died so far in the flash floods that occurred in Sikkim in the early hours of Wednesday.
'The situation in Nuh could have easily returned to normalcy if the trader class wished so, but they didn't.'
The government has ordered monoclonal antibody from Indian Council of Medical Research to treat the child. It is the only available anti-viral treatment for Nipah virus infection, though it has not been clinically proven yet.
PharmEasy has acquired Medlife for an undisclosed amount, the e-pharmacy unicorn said on Tuesday. The deal will make PharmEasy the largest player in the domestic online pharmacy sector, with the combined entity set to serve 2 million customers a month.
'The deaths of the children in the Gambia would batter India's reputation as the developing world's pharmacy.'
Samples of the cough syrup have been taken from the manufacturing premises in Noida and sent to the Regional Drugs Testing Laboratory (RDTL) in Chandigarh for testing, Mandaviya said.
Not only chemists, but several known private hospitals are selling medicines at higher prices than MRP, said Singh, adding that the matter was not peculiar to Punjab, but afflicts the whole country.
Brokerages have cut their estimates of listed diagnostics players for the financial year 2023-24 (FY24) after mixed December quarter results and muted near-term outlook. Their volumes and realisations will be under pressure due to weakness in Covid-adjusted performance and higher competitive pressures, the brokerages believe. In a post-Q3 results note on Dr Lal Pathlabs, Bhavesh Gandhi of YES Securities pointed out that there has been a lack of volume revival in recent quarters, with an increasing likelihood that FY24 too would be a work-in-progress year for the company's initiatives to bear fruit.
National Conference president Farooq Abdullah attended Kashmiri Pandit businessman Makhan Lal Bindroo's funeral on Wednesday.
Reinvent and innovate will be the key mantra for the Indian pharma industry in the New Year as the 'pharmacy of the world' looks to move from volume to value leadership, amid emerging challenges of inflation and pricing pressures in the global markets. While R&D investment, market competitiveness, regulatory scrutiny, and domestic price regulations are expected to shape the growth of generics and injectable products, concerns such as price control and customs duties on medical equipment will continue to bother the healthcare industry in 2023. The industry believes that in view of India's G20 Presidency, digital health innovation, achieving universal health coverage, improving healthcare infrastructure and delivery will continue to be the key driving factors in 2023.
That a brown skinned man -- albeit one who speaks with a posh English accent -- would one day be the front-runner in a race to elect Boris's successor and head the party once led by Churchill and Thatcher would seem indigestible to the white men and women who have formed the trunk of the Conservative party for generations.
Chinese President Xi Jinping's strict adherence to a 'zero COVID' policy had led to widespread civilian protests across the country.
Hospitals to recover from sluggish Q3; diagnostics' growth rate at pre-Covid levels.
The jury is still out on Chhatriwali's flimsy public service, but Rakul sure passes the quality check, applauds Sukanya Verma.
China on Monday reported the first fatalities in Shanghai due to the ongoing COVID-19 surge in the city where the Omicron variant continues to paralyse the country's business hub of 26 million people.
Once stability returns to the secondary market, companies that have obtained approval from Sebi will start tapping the market.
The Centre has asked traders and resellers of medical devices to register in an attempt to expand the ambit of regulating the medical devices industry in the country. The move can have far-reaching consequences for both consumers and traders alike as products like face masks or prophylactics - now sold through grocers and other channels - may face issues of availability. In a notification dated September 30, the union ministry of health and family welfare said anyone wanting to sell, stock, exhibit or offer for sale or distribute a medical device, including in-vitro diagnostic medical device, will need a certificate of registration.
Sensing a huge opportunity in the healthcare sector during the Covid-19 pandemic and its aftermath, private equity (PE) players are upping their investments in the space. According to data from research platform VCCEdge, the PEs have together invested a staggering $583.82 million in the first five months of 2021 in five deals, which is the highest investment in the sector in the last five calendar years - from 2016 to 2020. The second highest investment in the sector took place in 2017, when PEs invested $503 million in 18 deals, with an average deal size of $29. 9 million.
Two government school teachers, including a woman, were shot dead by terrorists in the Eidgah area of Srinagar on Thursday.
Rishi Sunak, one of the finalists in the race to succeed Boris Johnson as leader of the Conservative party and Britain's prime minister, is campaigning hard to win over the Tory faithful who will vote from today, July 28, to August 31 to elect their next leader.
During a sale, many store windows invite the shopper with impossible-to-miss visuals announcing '50% Discount'. Only upon entering does the shopper realises that the one rack which fulfils this promise sells items she'd never purchase.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances